# Peter M. Irving

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/peter-m-irving/

## Facts

| Field | Value |
| --- | --- |
| Citations | 19,998 |
| Field | Inflammatory Bowel Disease |
| h-index | 75 |
| i10-index | 210 |
| Last Known Institution | Guy's and St Thomas' NHS Foundation Trust |
| OpenAlex ID | https://openalex.org/A5031136418 |
| ORCID iD | https://orcid.org/0000-0003-0972-8148 |
| Works | 700 |

## Researcher papers

- [Gluten Causes Gastrointestinal Symptoms in Subjects Without Celiac Disease: A Double-Blind Randomized Placebo-Controlled Trial](https://scholariq.org/papers/gluten-causes-gastrointestinal-symptoms-in-subjects-without-celiac-disease-a/)
- [Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study](https://scholariq.org/papers/predictors-of-anti-tnf-treatment-failure-in-anti-tnf-naive-patients-with-active/)
- [Fermentable Carbohydrate Restriction Reduces Luminal Bifidobacteria and Gastrointestinal Symptoms in Patients with Irritable Bowel Syndrome](https://scholariq.org/papers/fermentable-carbohydrate-restriction-reduces-luminal-bifidobacteria-and/)
- [Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome](https://scholariq.org/papers/manipulation-of-dietary-short-chain-carbohydrates-alters-the-pattern-of-gas/)
- [Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome](https://scholariq.org/papers/comparison-of-symptom-response-following-advice-for-a-diet-low-in-fermentable/)
- [A Diet Low in FODMAPs Reduces Symptoms in Patients With Irritable Bowel Syndrome and A Probiotic Restores Bifidobacterium Species: A Randomized Controlled Trial](https://scholariq.org/papers/a-diet-low-in-fodmaps-reduces-symptoms-in-patients-with-irritable-bowel-syndrome/)
- [HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn’s Disease](https://scholariq.org/papers/hla-dqa1-05-carriage-associated-with-development-of-anti-drug-antibodies-to/)
- [Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial](https://scholariq.org/papers/effects-of-low-fodmap-diet-on-symptoms-fecal-microbiome-and-markers-of/)
- [Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial](https://scholariq.org/papers/ustekinumab-versus-adalimumab-for-induction-and-maintenance-therapy-in-biologic/)
- [A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial](https://scholariq.org/papers/a-biomarker-stratified-comparison-of-top-down-versus-accelerated-step-up/)
- [COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study](https://scholariq.org/papers/covid-19-vaccine-induced-antibody-responses-in-immunosuppressed-patients-with/)
- [Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study](https://scholariq.org/papers/mechanisms-and-management-of-loss-of-response-to-anti-tnf-therapy-for-patients/)

## Researcher topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Microscopic Colitis](https://scholariq.org/topics/microscopic-colitis/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)
- [Eosinophilic Esophagitis](https://scholariq.org/topics/eosinophilic-esophagitis/)
- [Gastrointestinal motility and disorders](https://scholariq.org/topics/gastrointestinal-motility-and-disorders/)

## Researcher university

- [Guy's and St Thomas' NHS Foundation Trust](https://scholariq.org/institutions/guy-s-and-st-thomas-nhs-foundation-trust/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.